CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Coronary calcification in the diagnosis of coronary artery disease Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women Noninvasive Nuclear SPECT Myocardial Blood Flow Quantitation to Guide Management for Coronary Artery Disease Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease

Editorial2019 Aug 7;40(30):2492-2494.

JOURNAL:Eur Heart J. Article Link

When, where, and how to target vascular inflammation in the post-CANTOS era?

Maffia P, Guzik TJ. Keywords: atherosclerosis; target vascular inflammation; CANTOS trial; secondary prevention; history of myocardidal infarction; IL-1 pathway

LINK


This editorial refers to ‘Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis’, by A. Vrommanetal., doi:10.1093/eurheartj/ehz008